Dr Jennifer Snaith
FRACP, MBBS (Hons), BMedSci
Dr Jennifer Snaith is an Endocrinologist and Research Fellow based at the Garvan Institute of Medical Research where she conducts clinical trials in type 1 diabetes as part of the AUSTAG group. Her career mission is to improve the lives of people living with type 1 diabetes through clinical service, advocacy and innovative research.
She is a Staff Specialist Endocrinologist at St Vincent's Hospital, and established with her team (Marhava/Lum/Higgins), the Diabetes in Youth (DIY) service i...
- Publications
- Awards
- Grants
- Teaching and Supervision
2024 - Australian Diabetes Society Lindsey Baudinet Rising Star Award in Type 1 Diabetes Research
2023 - Diabetes Australia Coghlan Award, for project 'Reducing Cardiometabolic Risk with Semaglutide in Type 1 Diabetes (RESET1)'
2022 - JDRF Rebecca Davies Fellowship
2022 - Australian Diabetes Society Clinical Young Investigator's Award
2021 - UNSW ARC Postgraduate Council Research Student Award
2020 - UNSW Visualise Your Thesis (Runner Up)
2020 - NHMRC Post Graduate Scholarship
2020 - NHMRC/Diabetes Australia co-funding award
2019 - UNSW University Post Graduate Award
2018 - Joan Waugh Scholarship for academic excellence and leadership potential
2018 - Westmead Association Tracey Robinson Registrar Award for Excellence in Teaching
2017 - Westmead Association Advanced Trainee of the Year
2015 - Westmead Association Tracey Robinson Registrar Award for Excellence in Teaching
2007 - University of Sydney Exchange Scholarship
2005 - Medical Science Scholarship
2024
- St Vincent’s Clinic Foundation Annual Grant $50,000, Snaith, JR (CI-A), Frampton R, Samocha-Bonet D, Greenfield JR, A Phase II study examining the effects of adjunctive tirzepatide on weight, metabolism and cardiovascular risk in adults with type 1 diabetes and obesity (the TIRTLE study)
- Australian Diabetes Society Lindsey Baudinet Rising Star in Type 1 Diabetes Award $20,000, Snaith JR (CI-A), Towards combo therapy: Tirzepatide for weight, metabolism and CV risk in adults with T1D and obesity (a phase II trial)'.
- MRFF 2023 TTRA – Cardiovascular Disease and Diabetes Mechanisms $916,315: Greenfield JR, Snaith JR (CI-B), Repurposed Semaglutide to Bridge the T1D Cardiovascular Risk Gap
2023
- Diabetes Australia Coghlan Award $150,000, Snaith JR (CI-A), Reducing Cardiometabolic Risk with Semaglutide in Type 1 Diabetes (RESET1)
2022
- JDRF Rebecca Davies Fellowship $142,500, Snaith JR (CI-A), Reducing Cardiometabolic Risk with Semaglutide in Type 1 Diabetes (RESET1)
- University of New South Wales Infrastructure Grant $200,651, Samocha-Bonet D, Snaith JR (CI-B), Greenfield JR, Chen R, Danta M, Jabbour A, Lim E, Patel S. BodPod and Q-NRG for extensive metabolic phenotyping
2021
- St Vincent’s Curran Foundation Endowment Grant $10,930, Snaith JR (CI-A), ‘Introducing rapid point of care HbA1c (Haemoglobin A1c) tests to SVH diabetes clinics’
- Cardiac, Vascular and Metabolic Medicine Theme Networking Seed Grant $30,000, Snaith JR (CI-A), Liu Z, Lovell N, Greenfield JR, ‘A novel online tool to diagnose double diabetes using biomarkers: towards cardiovascular risk reduction by personalised adjunctive treatment of insulin resistance in type 1 diabetes’
2020
- St Vincent’s Clinic Foundation Tancred Grant $50,000, Greenfield JR, Snaith J (CI-B), Holmes-Walker J, Girgis C, ‘INTIMET – Insulin Resistance in Type 1 Diabetes Managed with Metformin’
2019
- Diabetes Australia Millennium Grant (Type 1 Diabetes) $150,000, Greenfield JR, Snaith J (CI-B), Holmes Walker JR, Girgis C, Samocha-Bonet D, ‘Phenotypic Characterisation of Insulin-Sensitive and Insulin-Resistant Adults with Type 1 Diabetes’
My Research Supervision
UNSW PhD
- Dr R.Frampton: The Incretin Signature and the Role of Semaglutide in Type 1 Diabetes
UNSW Medicine Honours
- J.Yang: Repurposing Adjunctive Therapies in Type 1 Diabetes: A Patient Experience Survey
Previous research supervision:
UNSW Medicine Honours (B.Lamaro): An Unmet Needs Assessment in Type 1 Diabetes Mellitius: Rationale for Adjunctive Therapies?